Comparison of the multi-drug resistant human hepatocellular carcinoma cell line Bel-7402/ADM model established by three methods

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Zhong, Xingguo ^a,b   Xiong, Maoming ^a   Meng, Xiangling ^a   Gong, Renhua ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Anhui Provincial Corps Hospital of Chinese People's Armed Police Forces   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; ANTINEOPLASTIC AGENT; FLUOROURACIL; GLUTATHIONE; GLUTATHIONE TRANSFERASE; METHOTREXATE; MITOMYCIN; PLATINUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EXCRETION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; IC 50; LIVER TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; TIME; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; INHIBITORY CONCENTRATION 50; LIVER NEOPLASMS; MALE; METHOTREXATE; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOMYCIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGANOPLATINUM COMPOUNDS; P-GLYCOPROTEIN; TIME FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77955677452     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-115     Document Type: Article

References (23)

1. Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response. D Kessel V Botterill I Wodinsky, Cancer Res 1968 28 938 941 5652307
2. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. JL Biedler H Riehm, Cancer Res 1970 30 1174 1184 5533992
3. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. XD Zhou ZY Tang BH Yang ZY Lin ZC Ma SL Ye ZQ Wu J Fan LX Qin BH Zheng, Cancer 2001 91 1479 1486 10.1002/1097-0142(20010415)91: 8<1479::AID-CNCR1155>3.0.CO;2-0 11301395
4. Hepatectomy in the treatment of very big primary liver cancer: report of 86 cases. JM Yang T Kan H Chen MC Wu, Hepatobiliary Pancreat Dis Int 2002 1 42 45 14607621
5. Endocrine treatment of hepatocellular carcinoma. Any evidence of benefit? S Pignata B Daniele C Gallo R De Vivo S Monfardini F Perrone, Eur J Cancer 1998 34 25 32 10.1016/S0959-8049(97)00317-1 9624234
6. Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms. Y Urasaki T Ueda A Yoshida T Fukushima N Takeuchi T Tsuruo T Nakamura, Anticancer Res 1996 16 709 714 8687117
7. Biological characterization of multidrug-resistant human colon carcinoma sublines induced/selected by two methods. LY Yang JM Trujillo, Cancer Res 1990 50 3218 3225 2334917
8. Multidrug resistance in cancer: role of ATP-dependent transporters. MM Gottesman T Fojo SE Bates, Nat Rev Cancer 2002 2 48 58 10.1038/nrc706 11902585
9. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. RL Juliano V Ling, Biochim Biophys Acta 1976 455 152 162 10.1016/0005-2736(76)90160-7 990323
10. Multidrug resistance-associated protein expression in clinical gastric carcinoma. K Endo Y Maehara Y Ichiyoshi T Kusumoto Y Sakaguchi S Ohno K Sugimachi, Cancer 1996 77 1681 1687 8608562
11. Expression of the multidrug-resistance (MDR) gene in breast cancer. M Correnti ME Cavazza N Guedez O Herrera NR Suarez-Chacon, J Chemother 1995 7 449 451 8596130
12. P53 protein expression in human multidrug-resistant CEM lymphoblasts. N Rafki F Liautaud-Roger L Devy C Trentesaux J Dufer, Leuk Res 1997 21 147 152 10.1016/S0145-2126(96)00086-0 9112432
13. Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates BCL-2 expression in human myeloma cells. DS Siegel X Zhang R Feinman T Teitz A Zelenetz VM Richon RA Rifkind PA Marks J Michaeli, Proc Natl Acad Sci USA 1998 95 162 166 10.1073/pnas.95.1.162 9419346
14. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. KM Henkels JJ Turchi, Cancer Res 1999 59 3077 3083 10397248
15. The multidrug-resistance modifiers verapamil, cyclosporine A and tamoxifen induce an intracellular acidification in colon carcinoma cell lines in vitro. G Hamilton EP Cosentini B Teleky T Koperna J Zacheri M Riegler W Feil R Schiessel E Wenzi, Anticancer Res 1993 13 2059 2063 7905252
16. P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site. IL Urbatsch B Sankaran J Weber AE Senior, J Biol Chem 1995 270 19383 19390 10.1074/jbc.270.33.19383 7642618
17. Suppression of glucosylceramide synthase by RNA interference reverses multidrug resistance in human breast cancer cells. YL Sun GY Zhou KN Li P Gao QH Zhang JH Zhen YH Bai XF Zhang, Neoplasma 2006 53 1 8 16416005
18. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. KV Chin K Ueda I Pastan MM Gottesman, Science 1992 255 459 462 10.1126/science.1346476 1346476
19. Constitutive expression of the c-H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell line. K Nooter AW Boersma RG Oostrum H Burger AG Jochemsen G Stoter, Br J Cancer 1995 71 556 561 7880739
20. c-Ha-ras transfection and expression of MDR-related genes in MCF-10A human breast cell line. D Di Simone S Galimberti F Basolo F Ciardiello M Petrini RJ Scheper, Anticancer Res 1997 17 3587 3592 9413207
21. Multidrug resistance and cancer: the role of the human ABC transporter ABCG2. KF Ejendal CA Hrycyna, Curr Protein Pept Sci 2002 3 503 511 10.2174/1389203023380521 12369998
22. Recent progress in the development of anticancer agents. S Eckhardt, Curr Med Chem Anticancer Agents 2002 2 419 439 10.2174/1568011024606389 12678741
23. Expression of multidrug resistance-associated protein1, P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection. JH Choi HY Lim HJ Joo HS Kim JW Yi HC Kim YK Cho MW Kim KB Lee, Br J Cancer 2002 86 1578 1585 10.1038/sj.bjc.6600305 12085207